Discontinued — last reported Q4 '21

Other

R&D credit carryforward

Corvex R&D credit carryforward decreased by 60.0% to $1.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 60.0%, from $3.00M to $1.20M. Over 4 years (FY 2021 to FY 2025), R&D credit carryforward shows an upward trend with a 20.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2021

How to read this metric

Higher balances indicate a strong history of R&D investment that provides a future tax benefit, whereas lower balances suggest either lower R&D spending or successful utilization of credits.

Detailed definition

This metric tracks the value of research and development tax credits that have been earned but not yet utilized to offse...

Peer comparison

Standard for technology and AI infrastructure companies heavily invested in proprietary hardware and software development.

Metric ID: other_deferred_tax_assets_tax_credit_carryforwards_research

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$565.00K$1.20M$3.00M$3.00M$1.20M
QoQ Change+112.4%+150.0%+0.0%-60.0%
YoY Change+112.4%+150.0%+0.0%-60.0%
Range$565.00K$3.00M
CAGR+112.4%
Avg YoY Growth+50.6%
Median YoY Growth+56.2%

Frequently Asked Questions

What is Corvex 's r&d credit carryforward?
Corvex (MOVE) reported r&d credit carryforward of $1.20M in Q4 2025.
How has Corvex 's r&d credit carryforward changed year-over-year?
Corvex 's r&d credit carryforward decreased by 60.0% year-over-year, from $3.00M to $1.20M.
What is the long-term trend for Corvex 's r&d credit carryforward?
Over 4 years (2021 to 2025), Corvex 's r&d credit carryforward has grown at a 20.7% compound annual growth rate (CAGR), from $565.00K to $1.20M.
What does r&d credit carryforward mean?
Unused tax credits earned specifically from research and development activities.